1. Home
  2. SLN vs ASUR Comparison

SLN vs ASUR Comparison

Compare SLN & ASUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • ASUR
  • Stock Information
  • Founded
  • SLN 1994
  • ASUR 1985
  • Country
  • SLN United Kingdom
  • ASUR United States
  • Employees
  • SLN N/A
  • ASUR N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • ASUR EDP Services
  • Sector
  • SLN Health Care
  • ASUR Technology
  • Exchange
  • SLN Nasdaq
  • ASUR Nasdaq
  • Market Cap
  • SLN 268.8M
  • ASUR 258.8M
  • IPO Year
  • SLN N/A
  • ASUR 1992
  • Fundamental
  • Price
  • SLN $6.59
  • ASUR $8.46
  • Analyst Decision
  • SLN Buy
  • ASUR Strong Buy
  • Analyst Count
  • SLN 6
  • ASUR 6
  • Target Price
  • SLN $39.67
  • ASUR $13.42
  • AVG Volume (30 Days)
  • SLN 115.5K
  • ASUR 89.2K
  • Earning Date
  • SLN 11-13-2025
  • ASUR 10-31-2025
  • Dividend Yield
  • SLN N/A
  • ASUR N/A
  • EPS Growth
  • SLN N/A
  • ASUR N/A
  • EPS
  • SLN N/A
  • ASUR N/A
  • Revenue
  • SLN $27,169,000.00
  • ASUR $125,074,000.00
  • Revenue This Year
  • SLN N/A
  • ASUR $18.68
  • Revenue Next Year
  • SLN N/A
  • ASUR $13.03
  • P/E Ratio
  • SLN N/A
  • ASUR N/A
  • Revenue Growth
  • SLN 22.28
  • ASUR 8.48
  • 52 Week Low
  • SLN $1.97
  • ASUR $7.51
  • 52 Week High
  • SLN $19.36
  • ASUR $12.74
  • Technical
  • Relative Strength Index (RSI)
  • SLN 69.56
  • ASUR 55.23
  • Support Level
  • SLN $5.00
  • ASUR $8.01
  • Resistance Level
  • SLN $5.83
  • ASUR $8.45
  • Average True Range (ATR)
  • SLN 0.41
  • ASUR 0.23
  • MACD
  • SLN 0.16
  • ASUR 0.06
  • Stochastic Oscillator
  • SLN 93.42
  • ASUR 70.15

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About ASUR Asure Software Inc

Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its HCM products majorly in the United States.

Share on Social Networks: